RETATRUTIDE RAW

RETRUTIDE 10MG LYOPHILIZED POWDER IN A 3ML VIAL.

Retatrutide is an investigational, long-acting tri-agonist peptide targeting the GLP-1, GIP, and glucagon receptors. In preclinical and clinical studies, it has been evaluated for its effects on body weight reduction, glycemic control, and metabolic regulation. The compound demonstrates multi-pathway modulation of energy balance, including appetite suppression and increased energy expenditure, making it a subject of interest in obesity and metabolic disorder research.